|
GBE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.87680000002844E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17659999999231E-05 |
| Normal-vs-Stage2 |
1.117920E-02 |
| Normal-vs-Stage3 |
4.758000E-03 |
| Normal-vs-Stage4 |
6.16780000000094E-05 |
| Stage1-vs-Stage2 |
9.574400E-01 |
| Stage1-vs-Stage3 |
9.664000E-01 |
| Stage1-vs-Stage4 |
3.593200E-01 |
| Stage2-vs-Stage3 |
9.465800E-01 |
| Stage2-vs-Stage4 |
5.427400E-01 |
| Stage3-vs-Stage4 |
4.566000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.8127999997003E-07 |
| Normal-vs-AfricanAmerican |
7.728500E-02 |
| Normal-vs-Asian |
9.055800E-02 |
| Caucasian-vs-AfricanAmerican |
4.804800E-01 |
| Caucasian-vs-Asian |
9.054800E-01 |
| AfricanAmerican-vs-Asian |
8.892800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80379999825675E-08 |
| Normal-vs-Female |
2.056400E-02 |
| Male-vs-Female |
1.447790E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.997670E-02 |
| Normal-vs-Age(41-60Yrs) |
8.23859999999899E-05 |
| Normal-vs-Age(61-80Yrs) |
3.69370000000702E-05 |
| Normal-vs-Age(81-100Yrs) |
1.030750E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.264400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.018800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.111200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.237400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.176400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.715200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.185000E-01 |
| Normal-vs-Grade 2 |
3.993200E-04 |
| Normal-vs-Grade 3 |
1.34530000028832E-07 |
| Normal-vs-Grade 4 |
3.368500E-04 |
| Grade 1-vs-Grade 2 |
3.072000E-02 |
| Grade 1-vs-Grade 3 |
5.986300E-02 |
| Grade 1-vs-Grade 4 |
6.382400E-02 |
| Grade 2-vs-Grade 3 |
2.237800E-01 |
| Grade 2-vs-Grade 4 |
4.304200E-01 |
| Grade 3-vs-Grade 4 |
9.883000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.774370E-04 |
| Normal-vs-ccB subtype |
4.682600E-03 |
| ccA subtype-vs-ccB subtype |
7.842000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00479999999947E-05 |
| Normal-vs-N1 |
5.569200E-01 |
| N0-vs-N1 |
7.069600E-01 |
|
|
